Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement.

Chery, Godefroy S; Kamp, Nicholas; Kosinski, Andrzej S; Schmidler, Gillian Sanders; Lopes, Renato D; Patel, Manesh; Al-Khatib, Sana M

Chery, Godefroy S; Kamp, Nicholas; Kosinski, Andrzej S; Schmidler, Gillian Sanders; Lopes, Renato D; Patel, Manesh; Al-Khatib, Sana M.

Afiliação

Chery GS; Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, 2241 Sears Street, Philadelphia, PA, 19146.
Kamp N; Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH.
Kosinski AS; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC.
Schmidler GS; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC; Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
Lopes RD; Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
Patel M; Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
Al-Khatib SM; Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

Am Heart J ; 233: 151-152, 2021 03.

Article em En | MEDLINE | ID: mdl-33610195

Assuntos

Cardiomiopatias; Desfibriladores Implantáveis; Fibrose; Humanos; Imageamento por Ressonância Magnética; Prognóstico

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desfibriladores Implantáveis / Cardiomiopatias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google